Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Pol

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
EMBO Molecular Medicine|April 24, 2020
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stressJuliette Humeau, Allan Sauvat, Giulia Cerrato, et al.
Journal of Virological Methods|October 22, 2008
Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoringJonathan Pol, Catherine Le Pendeven, Agnes Beby-Defaux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost VaccinationByram W Bridle, Andrew Nguyen, Omar Salem, et al.
Journal for Immunotherapy of Cancer|April 28, 2022
Local anesthetics elicit immune-dependent anticancer effectsLucillia Bezu, Alejandra Wu Chuang, Allan Sauvat, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Oncolytic viruses and cancer therapyJonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
Journal for Immunotherapy of Cancer|June 30, 2022
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancerPan Juncheng, Adrien Joseph, Antoine Lafarge, et al.
Autophagy|January 7, 2017
Metabolic effects of fasting on human and mouse blood in vivoFederico Pietrocola, Yohann Demont, Francesca Castoldi, et al.
Cancer Immunology Research|September 16, 2017
Customized Viral Immunotherapy for HPV-Associated CancerMatthew J Atherton, Kyle B Stephenson, Jonathan Pol, et al.
Hepatology (Baltimore, Md.)|October 2, 2025
Laser-activated nanoparticles rewire tumor microenvironment enhancing PD-1 blockade and T cell response in cholangiocarcinomaMirko Minini, Giulio Avveduto, Sonia Becharef, et al.
Molecular Therapy Oncolytics|March 14, 2022
NAD+ depletion enhances reovirus-induced oncolysis in multiple myelomaBarry E Kennedy, Michael Giacomantonio, J Patrick Murphy, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
EMBO Molecular Medicine|April 24, 2020
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stressJuliette Humeau, Allan Sauvat, Giulia Cerrato, et al.
Journal of Virological Methods|October 22, 2008
Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoringJonathan Pol, Catherine Le Pendeven, Agnes Beby-Defaux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost VaccinationByram W Bridle, Andrew Nguyen, Omar Salem, et al.
Journal for Immunotherapy of Cancer|April 28, 2022
Local anesthetics elicit immune-dependent anticancer effectsLucillia Bezu, Alejandra Wu Chuang, Allan Sauvat, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Oncolytic viruses and cancer therapyJonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
Journal for Immunotherapy of Cancer|June 30, 2022
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancerPan Juncheng, Adrien Joseph, Antoine Lafarge, et al.
Autophagy|January 7, 2017
Metabolic effects of fasting on human and mouse blood in vivoFederico Pietrocola, Yohann Demont, Francesca Castoldi, et al.
Cancer Immunology Research|September 16, 2017
Customized Viral Immunotherapy for HPV-Associated CancerMatthew J Atherton, Kyle B Stephenson, Jonathan Pol, et al.
Hepatology (Baltimore, Md.)|October 2, 2025
Laser-activated nanoparticles rewire tumor microenvironment enhancing PD-1 blockade and T cell response in cholangiocarcinomaMirko Minini, Giulio Avveduto, Sonia Becharef, et al.
Molecular Therapy Oncolytics|March 14, 2022
NAD+ depletion enhances reovirus-induced oncolysis in multiple myelomaBarry E Kennedy, Michael Giacomantonio, J Patrick Murphy, et al.
Pageof 7